Crossmark

Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

Crossref DOI link: https://doi.org/10.1016/j.arbres.2024.04.008

Published Print: 2024-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Agusti, Alvar

Lopez-Campos, José Luis

Miravitlles, Marc

Soler-Cataluña, Juan Jose

Marin, Jose Maria

Cosio, Borja G.

Alcázar-Navarrete, Bernardino

Echave-Sustaeta, Jose Maria

Casanova, Ciro

Peces-Barba, German

de-Torres, Juan Pablo

Fernandez-Villar, Alberto

Ancochea, Julio

Villar-Alvarez, Felipe

Roman-Rodriguez, Miguel

Molina, Jesus

Garcia-Rivero, Juan Luis

Gonzalez, Cruz

Sobradillo, Patricia

Faner, Rosa

Peña, Carolina

Sharma, Raj

Izquierdo, José Luis

Celli, Bartolome R.
Funding

Funding for this research was provided by:

GSK
License Information

Text and Data Mining valid from 2024-07-01

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-04-29
More Information

This article is maintained by: Elsevier

Article Title: Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2024.04.008

Content Type: article

Copyright: © 2024 The Authors. Published by Elsevier España, S.L.U. on behalf of SEPAR.